About Apicore
Apicore is a company based in Somerset (United States) founded in 2004 was acquired by Medicure in July 2017.. Apicore has raised $720.12 thousand across 2 funding rounds from investors including Medicure, Knight Therapeutics and Signet Healthcare Partners. The company has 471 employees as of April 09, 2024. Apicore operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Somerset, United States
- Employees 471 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Apicore Pharmaceuticals Private Limited
- Date of Incorporation 27 Jul, 2006
- Jurisdiction Vadodara, Gujarat, India
-
Annual Revenue
$15.24 M (USD)0as on Mar 31, 2023
-
Net Profit
$-1.28 M (USD)0as on Mar 31, 2023
-
EBITDA
$751.03 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$720.12 K (USD)
in 2 rounds
-
Latest Funding Round
$720.12 K (USD), Series A
Oct 05, 2016
-
Investors
Medicure
& 2 more
-
Employee Count
471
as on Apr 09, 2024
-
Acquired by
Medicure
(Jul 12, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apicore
Apicore has successfully raised a total of $720.12K across 2 strategic funding rounds. The most recent funding activity was a Series A round of $720.12 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $720,118
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Series A - Apicore | Valuation |
investors |
|
| Jul, 2014 | Amount | Series A - Apicore | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Apicore
Apicore has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Medicure, Knight Therapeutics and Signet Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location | |
|
Affordable therapeutics are developed and e-commerce pharmacy services are provided.
|
Founded Year | Domain | Location | |
|
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Apicore
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Apicore
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Apicore Comparisons
Competitors of Apicore
Apicore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Apicore
Frequently Asked Questions about Apicore
When was Apicore founded?
Apicore was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Where is Apicore located?
Apicore is headquartered in Somerset, United States.
Is Apicore a funded company?
Apicore is a funded company, having raised a total of $720.12K across 2 funding rounds to date.
How many employees does Apicore have?
As of Apr 09, 2024, the latest employee count at Apicore is 471.
What is the annual revenue of Apicore?
Annual revenue of Apicore is $15.24M as on Mar 31, 2023.
What does Apicore do?
Apicore was founded in 2004 in Somerset, United States, within the pharmaceutical chemicals sector. Active pharmaceutical ingredients (APIs) are produced, alongside custom synthesis for early-phase research. A portfolio of 100 API products is maintained, with synthesis capabilities encompassing carbohydrates, nucleosides, prostaglandins, diagnostic agents, liquid APIs, potent compounds, peptides, and complex small molecules. Operations extend to 16 countries globally.
Who are the top competitors of Apicore?
Apicore's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Who are Apicore's investors?
Apicore has 3 investors. Key investors include Medicure, Knight Therapeutics, and Signet Healthcare Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.